Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06284629 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Enhancing Referral Decision-making for Advanced Treatment in Parkinson's Disease Through Objective Measurements and Patient Reported Outcomes.

Study acronym: PD-DigiCare
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 21, 2024 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Jun 2024); last known: Not Yet Recruiting
  2. Start date: Sep 1, 2024 to Oct 1, 2024v4 Show 4 more changesShow less
    • Study sites: 3 to 2
    • Primary and study completion dates: Sep 1, 2026 to Oct 1, 2026
    • Collaborators: 2 to 1
    • Study description shortened, about 5 words
  3. Secondary endpoints: details revised at 7 of 7 entriesv3
  4. Primary endpoints: 2 to 1
    • Eligibility criteria shortened, about 24 words
    • Secondary endpoints revised (7)
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall aim of the trial is to compare the efficacy of using wearables and patient-reported outcome measures versus standard care in enhancing the timeliness of referrals to advanced monitoring of treatments for people with Parkinson's Disease.
Trial Details
NCT Number NCT06284629
Lead Sponsor Copenhagen University Hospital, Rigshospitalet
Collaborators: Odense University Hospital
Conditions
(from sponsor)		 Parkinson Disease
Related terms Parkinson Disease
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov